STUDY DESIGN: This study is a prospective review of all spinal cord monitoring procedures in our unit from 1999 to 2004 in patients undergoing spinal deformity correction surgery. OBJECTIVE: To report the sensitivity and specificity of transcranial motor-evoked potentials (MEP) and compound muscle action potential (CMAP) monitoring as the sole modality in spinal deformity correction surgery. SUMMARY OF BACKGROUND DATA: Combined spinal cord monitoring with somatosensory-evoked potentials and MEP has been widely used. The use of CMAP as the only modality has not been widely used and its efficacy has not been fully elucidated. METHODS: The intraoperative monitoring outcomes were compared with patient's postoperative clinical outcomes. The sensitivity and specificity were calculated and determined for our monitoring protocol. RESULTS: Transcranial MEPs were measured in 144 patients in 172 procedures. In 2 patients (3 procedures), we were unable to record any CMAPs. There were 15 intraoperative monitoring changes. There were no new postoperative neurological deficits. CONCLUSION: The monitoring criteria are sufficiently strict to achieve a sensitivity of 1.0 and a specificity of 0.97. Monitoring of CMAPs alone has been adequate to avoid clinical neurological deficits.
STUDY DESIGN: This study is a prospective review of all spinal cord monitoring procedures in our unit from 1999 to 2004 in patients undergoing spinal deformity correction surgery. OBJECTIVE: To report the sensitivity and specificity of transcranial motor-evoked potentials (MEP) and compound muscle action potential (CMAP) monitoring as the sole modality in spinal deformity correction surgery. SUMMARY OF BACKGROUND DATA: Combined spinal cord monitoring with somatosensory-evoked potentials and MEP has been widely used. The use of CMAP as the only modality has not been widely used and its efficacy has not been fully elucidated. METHODS: The intraoperative monitoring outcomes were compared with patient's postoperative clinical outcomes. The sensitivity and specificity were calculated and determined for our monitoring protocol. RESULTS: Transcranial MEPs were measured in 144 patients in 172 procedures. In 2 patients (3 procedures), we were unable to record any CMAPs. There were 15 intraoperative monitoring changes. There were no new postoperative neurological deficits. CONCLUSION: The monitoring criteria are sufficiently strict to achieve a sensitivity of 1.0 and a specificity of 0.97. Monitoring of CMAPs alone has been adequate to avoid clinical neurological deficits.
Authors: Anastasios Charalampidis; Fan Jiang; Jamie R F Wilson; Jetan H Badhiwala; Darrel S Brodke; Michael G Fehlings Journal: Global Spine J Date: 2020-01-06